Detection of Ileoanal Pouch/Reservoir Adenomas
Launched by JEAN CHRISTOPHE SAURIN · Jul 11, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a method to better detect adenomas, which are abnormal growths that can develop into cancer, in patients who have had surgery for familial adenomatous polyposis. These patients often have an ileal pouch, a type of surgical reservoir created after removing the colon. The researchers believe that using a special dye called indigo-carmine during a procedure called chromoendoscopy will help spot these adenomas more easily, especially since they can be flat and tricky to find.
To participate in the trial, candidates must have familial adenomatous polyposis and an ileo-anal anastomosis with a pouch reservoir. They also need to have a high-quality preparation for the procedure. If you or a loved one meets these criteria, you may have the opportunity to be part of this important study, which aims to improve cancer screening and potentially lower cancer risks for this group of patients. Participants can expect to undergo procedures with the indigo-carmine dye, which could enhance the detection of adenomas.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with familial adenomatous polyposis
- • Ileo-anal anastomosis with pouch reservoir
- • Quality of the final preparation = 3 (excellent) on the studied area
- • Films made under optimal conditions for the 3 staining methods
- Exclusion Criteria:
- • Patient with no familial adenomatous polyposis
- • Patient without Ileo-anal anastomosis reservoir
- • Insufficient quality of the final preparation \<3
- • Absence of films made under optimal conditions for the 3 staining methods
About Jean Christophe Saurin
Jean Christophe Saurin is a dedicated clinical trial sponsor known for its commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, the organization collaborates with healthcare professionals, regulatory bodies, and research institutions to conduct rigorous clinical trials across various therapeutic areas. Jean Christophe Saurin emphasizes ethical standards, patient safety, and scientific integrity, ensuring that all studies adhere to the highest regulatory requirements. Through its strategic partnerships and cutting-edge research methodologies, the sponsor aims to contribute significantly to the development of new treatments and enhance the overall quality of care in the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported